TRIP
57
-13
O
28
8
PEP
29
-3
CRM
55
-4
TGT
58
4
AMAT
44
-4
BDX
63
-2
ROK
32
-2
L
43
-4
BF.B
25
-4
KMB
28
-2
JBHT
48
-2
WFC
47
-8
CAT
44
-4
GOOG
61
-4
MAC
40
-8
PRU
33
-4
PX
50
-9
V
42
-8
ACN
50
-6
TRIP
57
-13
O
28
8
PEP
29
-3
CRM
55
-4
TGT
58
4
AMAT
44
-4
BDX
63
-2
ROK
32
-2
L
43
-4
BF.B
25
-4
KMB
28
-2
JBHT
48
-2
WFC
47
-8
CAT
44
-4
GOOG
61
-4
MAC
40
-8
PRU
33
-4
PX
50
-9
V
42
-8
ACN
50
-6
Financhill
Back

Generac Holdings Vs. Intra-Cellular Therapies Industry Stock Comparison

Buy
53

GNRC
Generac Holdings

Last Price:
$157.45
Seasonality Move:
4.39%
Sell
42

ITCI
Intra-Cellular Therapies

Last Price:
$94.86
Seasonality Move:
2.9%
Buy
53
Generac Holdings (GNRC) is a Buy

Is Generac Holdings a Buy, Sell or Hold?

  • The current Generac Holdings [GNRC] share price is $157.44. The Score for GNRC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • GNRC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $94.87. The Score for ITCI is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GNRC Stock Price Chart

What is Generac Holdings's stock price today?

  • The Generac Holdings share price today is $157.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GNRC is experiencing buying pressure, which is a positive indicator for future bullish movement.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $94.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight buying pressure.

GNRC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.41 Sell
Relative Strength Index (14 RSI): 36.55 Sell
Chaikin Money Flow: 491157 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (154.52 - 172.56) Sell
Bollinger Bands (100): (149.64 - 179.3) Sell

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.52 Buy
Relative Strength Index (14 RSI): 71.02 Buy
Chaikin Money Flow: 1717350 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (82.26 - 87.1) Buy
Bollinger Bands (100): (74.04 - 85.96) Buy

GNRC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 157.85 Sell
20-day SMA: 159.93 Sell
50-day SMA: 173.24 Sell
200-day SMA: 152.64 Buy
8-day EMA: 158.39 Sell
20-day EMA: 161.68 Sell
50-day EMA: 166.45 Sell
200-day EMA: 154.34 Buy

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.68 Buy
20-day SMA: 84.71 Buy
50-day SMA: 85.48 Buy
200-day SMA: 75.72 Buy
8-day EMA: 85.91 Buy
20-day EMA: 85.03 Buy
50-day EMA: 83.75 Buy
200-day EMA: 76.64 Buy

Generac Holdings Earnings Growth & GNRC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.27 per share, and an increase next year of $1.14 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $3.25 per share.

Generac Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):